Logo GE HealthCare

GE HealthCare (GEHC) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
GE HealthCare · Health Care · ref. ETF XLV · 50 calls · price $72.48
💬JPI AI AssistantTry it →
What the company does: GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.

📈 GE HealthCare (GEHC) stock price

$72.48-1.7% over range
Aug 28, 25low $59.49 · high $88.16Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
46% recommend buying · 13 analysts
📊 JPI status : GE HealthCare has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 GEHC price target & analyst consensusprice $72.48

The price target · all analysts combined (13 targets)
Highest target · 1 firm of 13$90+24.2%
Median target · of 13 targets$78.5+8.3%
Lowest target · 1 firm of 13$65-10.3%
Current price$72.48
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 969% $73 ↔ $90
Below 431% $14 ↔ $70
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BMO Capital73% of its targets hit on this sector (239 calls tested). It aims for $70 (-3.4 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).

The 5 reliable analysts $75+3.5 %
The 8 other firms $79+9.0 %
How to read it: the 5 reliable firms are not filtered by optimism — 4 aim above the price, 1 below, hence their $75 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy646%
Hold754%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about GE HealthCare? The JPI assistant answers using our backtest data.

💰 GE HealthCare dividend: yield, history & growth › open the full page

0.22%annual yield
That's ~$0.14 per share per year.

📈 GE HealthCare fundamentals: valuation, margins & growth › open the full page

P/E 16.9Net margin 9.3 %Revenue growth +5.8 %Cheap for the growth

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 10 %
2023
Rev +7%Profit −18%
2024
Rev +1%Profit +27%
2025
Rev +5%Profit +5%

🏛️ GE HealthCare insider buying: who's buying and how much › open the full page

8 insiders bought8 buys / 6 mo $6.4M👥 Cluster buy

🔎 Detailed analyses

✅ Historical analyst reliability on GEHC

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
UBS  50% +2.3% 2
Piper Sandler  50% +0.8% 2
Mizuho  50% -0.9% 6
Wells Fargo  25% -4.8% 4
Evercore ISI Group  25% -9.0% 4
Citigroup  17% -5.7% 6
Goldman Sachs  0% -14.3% 2
Stifel  0% -17.1% 2

📊 What $1,000 invested in GE HealthCare would be worth › open the full page

In short — $1,000 invested in GE HealthCare 10 years ago would be worth $1,128 today, i.e. +3%/yr on average. Best year: 2023 (+32%), worst: 2025 (+3%). Price performance, excluding dividends.

If I'd invested $1,000 in GE HealthCare

InvestmentWorth todayGain
1 years ago$795-21%
3 years ago$1,096+10%
→ See GE HealthCare's full return history + gain calculator

Return by year (GE HealthCare)

YearReturn$1,000 invested at year start
2026 (YTD)-23%$773 (-23%)
2025+3%$795 (-21%)
2024+4%$828 (-17%)
→ See GE HealthCare's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on GE HealthCare

Loading news…

📋 All analyst calls on GEHC

BTIG 
Aug 19, 26
▲ Buy · 🎯$79
Price at call : $74.62 — upside +6%
Today : $72.48 — upside +9%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Aug 19, 27
UBS 
Jul 31, 26
■ Neutral neutral · not a buy · 🎯$73
Price at call : $69.73 — gap to target +5%
Today : $72.48 — gap to target +1%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 31, 27
Citigroup 
Jul 30, 26
■ Neutral neutral · not a buy · 🎯$75
Price at call : $68.02 — gap to target +10%
Today : $72.48 — gap to target +3%
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 30, 27
▲ Outperform · 🎯$84
Price at call : $68.02 — upside +23%
Today : $72.48 — upside +16%
🎯 on GEHC : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 30, 27
Wells Fargo 
Jul 30, 26
▲ Overweight · 🎯$85
Price at call : $68.02 — upside +25%
Today : $72.48 — upside +17%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 30, 27
BTIG 
Jul 29, 26
▲ Buy · 🎯$79
Price at call : $69.94 — upside +13%
Today : $72.48 — upside +9%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jul 29, 27
Hovde Group
Jul 17, 26
■ Market Perform neutral · not a buy · 🎯$14
Price at call : $62.83 — gap to target -78%
Today : $72.48 — gap to target -81%
🎯 on GEHC : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 17, 27
UBS 
Jul 16, 26
■ Neutral neutral · not a buy · 🎯$67
Price at call : $63.07 — gap to target +6%
Today : $72.48 — gap to target -8%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 16, 27
See the other 42 calls, newest to oldest
BMO Capital 
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$70
Price at call : $64.7 — gap to target +8%
Today : $72.48 — gap to target -3%
🎯 on GEHC : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Jul 9, 27
RBC Capital 
Jun 23, 26
▲ Outperform · 🎯$80
Price at call : $64.88 — upside +23%
Today : $72.48 — upside +10%
🎯 on GEHC : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jun 23, 27
UBS 
May 21, 26
■ Neutral neutral · not a buy · 🎯$69
Price at call : $64.23 — gap to target +7%
Today : $72.48 — gap to target -5%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 21, 27
JP Morgan 
May 1, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $61.03 — gap to target +7%
Today : $72.48 — gap to target -10%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : May 1, 27
Citigroup 
Apr 30, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $61.03 — gap to target +7%
Today : $72.48 — gap to target -10%
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 30, 27
Goldman Sachs 
Apr 30, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $61.03 — gap to target +7%
Today : $72.48 — gap to target -10%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 30, 27
Barclays 
Apr 30, 26
■ Equal-Weight neutral · not a buy · 🎯$78
Price at call : $61.03 — gap to target +28%
Today : $72.48 — gap to target +8%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 30, 27
▲ Outperform · 🎯$80
Price at call : $61.03 — upside +31%
Today : $72.48 — upside +10%
🎯 on GEHC : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 30, 27
Wells Fargo 
Apr 30, 26
▲ Overweight · 🎯$75
Price at call : $60.84 — upside +23%
Today : $72.48 — upside +3%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Apr 30, 27
BTIG 
Apr 29, 26
▲ Buy · 🎯$80
Price at call : $60.84 — upside +31%
Today : $72.48 — upside +10%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 29, 27
BTIG 
Apr 21, 26
▲ Buy · 🎯$85
Price at call : $72.26 — upside +18%
Today : $72.48 — upside +17%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 21, 27
Piper Sandler 
Apr 17, 26
▲ Overweight · 🎯$88
Price at call : $74.15 — upside +19%
Today : $72.48 — upside +21%
🎯 on GEHC : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Apr 17, 27
Mizuho 
Apr 13, 26
▲ Outperform · 🎯$90
Price at call : $74.67 — upside +21%
Today : $72.48 — upside +24%
🎯 on GEHC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Apr 13, 27
Goldman Sachs 
Apr 9, 26
▲ Buy · 🎯$81
Price at call : $73.18 — upside +11%
Today : $72.48 — upside +12%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 9, 27
▲ Outperform · 🎯$85
Price at call : $69.73 — upside +22%
Today : $72.48 — upside +17%
🎯 on GEHC : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
BTIG 
Mar 19, 26
▲ Buy · 🎯$91
Price at call : $70.38 — upside +29%
Today : $72.48 — upside +26%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Mar 19, 27
Citigroup 
Mar 11, 26
■ Neutral neutral · not a buy · 🎯$84
Price at call : $70.33 — gap to target +19%
Today : $72.48 — gap to target +16%
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Mar 11, 27
BTIG 
Feb 9, 26
▲ Buy · 🎯$91
Price at call : $79.08 — upside +15%
Today : $72.48 — upside +26%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Feb 9, 27
Barclays 
Feb 6, 26
■ Equal-Weight neutral · not a buy · 🎯$87
Price at call : $79.08 — gap to target +10%
Today : $72.48 — gap to target +20%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 6, 27
Stifel 
Feb 5, 26
▲ Buy · 🎯$98
Price at call : $80.65 — upside +22%
Today : $72.48 — upside +35%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Feb 5, 27
▲ Outperform · 🎯$98
Price at call : $80.65 — upside +22%
Today : $72.48 — upside +35%
🎯 on GEHC : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Feb 5, 27
Wells Fargo 
Feb 5, 26
▲ Overweight · 🎯$97
Price at call : $82.31 — upside +18%
Today : $72.48 — upside +34%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 5, 27
■ Equal-Weight neutral · not a buy · 🎯$85
Price at call : $82.31 — gap to target +3%
Today : $72.48 — gap to target +17%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Feb 5, 27
BTIG 
Feb 4, 26
▲ Buy · 🎯$91
Price at call : $82.31 — upside +11%
Today : $72.48 — upside +26%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Feb 4, 27
Piper Sandler 
Jan 30, 26
▲ Overweight · 🎯$94
Price at call : $80.11 — upside +17%
Today : $72.48 — upside +30%
🎯 on GEHC : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jan 30, 27
UBS 
Jan 15, 26
▼ Sell · 🎯$77
Price at call : $81.75 — upside -6%
Today : $72.48 — upside +6%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jan 15, 27
Stifel 
Jan 7, 26
▲ Buy · 🎯$95
Price at call : $85.76 — upside +11%
Today : $72.48 — upside +31%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jan 7, 27
■ Neutral neutral · not a buy · 🎯$92
Price at call : $85.04 — gap to target +8%
Today : $72.48 — gap to target +27%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jan 5, 27
Citigroup 
Dec 11, 25
■ Neutral neutral · not a buy · 🎯$88
Price at call : $83.96 — gap to target +5%
Today : $72.48 — gap to target +21%
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Dec 11, 26
Jefferies 
Dec 11, 25
▲ Buy · 🎯$105
Price at call : $83.96 — upside +25%
Today : $72.48 — upside +45%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Dec 11, 26
BTIG 
Nov 21, 25
▲ Buy · 🎯$87
Price at call : $76.45 — upside +14%
Today : $72.48 — upside +20%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Nov 21, 26
Morgan Stanley 
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$80
Price at call : $74.95 — gap to target +7%
Today : $72.48 — gap to target +10%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Oct 30, 26
▲ Outperform · 🎯$92
Price at call : $74.95 — upside +23%
Today : $72.48 — upside +27%
🎯 on GEHC : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo 
Oct 30, 25
▲ Overweight · 🎯$87
Price at call : $74.95 — upside +16%
Today : $72.48 — upside +20%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Oct 30, 26
BTIG 
Oct 13, 25
▲ Buy · 🎯$89
Price at call : $71.84 — upside +24%
Today : $72.48 — upside +23%
🎯 on GEHC : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Oct 13, 26
Barclays 
Oct 13, 25
■ Equal-Weight neutral · not a buy · 🎯$86
Price at call : $71.84 — gap to target +20%
Today : $72.48 — gap to target +19%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 13, 26
Citigroup 
Oct 7, 25
■ Neutral neutral · not a buy · 🎯$83
Price at call : $74.49 — gap to target +11%
Today : $72.48 — gap to target +15%
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Oct 7, 26
Citigroup 
Aug 1, 25
▲ Buy · 🎯$93
Price at call : $69.85 — upside +33%
Today : $72.48 — upside +28%
Expected +33% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-0.2%
stock -0% · XLV +24%
matured Aug 1, 26
Morgan Stanley 
Jul 31, 25
■ Equal-Weight neutral · not a buy · 🎯$74
Price at call : $69.85 — gap to target +6%
Today : $72.48 — gap to target +2%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 31, 26
Citigroup 
Jul 9, 25
▲ Buy · 🎯$89
Price at call : $76.5 — upside +16%
Today : $72.48 — upside +23%
Expected +16% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on GEHC : 0% (2 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-15.4%
stock -15% · XLV +18%
matured Jul 9, 26
■ Equal-Weight neutral · not a buy · 🎯$78
Price at call : $68.82 — gap to target +13%
Today : $72.48 — gap to target +8%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : May 6, 26
UBS 
May 5, 25
■ Neutral neutral · not a buy · 🎯$73
Price at call : $67.09 — gap to target +9%
Today : $72.48 — gap to target +1%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 5, 26

Frequently asked questions

Should I buy GE HealthCare stock?

This isn't buy advice. For GE HealthCare, the analyst consensus is "Hold", with an average price target of $78.50 (+8% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on GE HealthCare). We show the numbers — you decide.

Is it too late to buy GE HealthCare? How high can it go?

The most bullish analyst target on GE HealthCare is $90.00 (+24% above today's price); the average is $78.50. That's the upside they see. Check how reliable those analysts have actually been on GE HealthCare on our site before trusting it.

Is GE HealthCare still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on GE HealthCare, the best hitting 50% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in GE HealthCare? The case for and against

The arguments for and against, one by one, from the numbers: why invest in GEHC (and why hesitate).

What has GE HealthCare's past performance been?

Historical returns and a "how much if I had invested" calculator: GEHC performance & returns.

Does GE HealthCare pay a dividend?

Yield, consistency and growth history of the dividend: GEHC's dividend.

Are insiders buying GEHC stock?

Executives' and large holders' buys and sells, decoded: insider buying on GEHC.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)